Edition:
United States

Histogenics Corp (HSGX.OQ)

HSGX.OQ on NASDAQ Stock Exchange Capital Market

2.69USD
4:00pm EDT
Change (% chg)

$-0.03 (-1.10%)
Prev Close
$2.72
Open
$2.74
Day's High
$2.74
Day's Low
$2.68
Volume
9,356
Avg. Vol
22,238
52-wk High
$3.26
52-wk Low
$1.59

Select another date:

Fri, Jan 26 2018

BRIEF-Perceptive Advisors LLC Reports 8.8 pct Passive Stake In Histogenics As Of Jan. 17

* PERCEPTIVE ADVISORS LLC REPORTS 8.8 PERCENT PASSIVE STAKE IN HISTOGENICS CORP AS OF JANUARY 17, 2018 - SEC FILING‍​ Source text - (http://bit.ly/2GlVfLJ) Further company coverage:

BRIEF-Histogenics Announces Pricing Of Underwritten Registered Direct Offering

* ANNOUNCES PRICING OF UNDERWRITTEN REGISTERED DIRECT OFFERING OF 2,340,430 SHARES OF COMMON STOCK

BRIEF-Histogenics And Medinet Enter Licensing Agreement For Commercialization Of NeoCart In Japan

* HISTOGENICS CORPORATION AND MEDINET CO., LTD ENTER INTO LICENSING AGREEMENT FOR DEVELOPMENT AND COMMERCIALIZATION OF NEOCART FOR THE JAPANESE MARKET

BRIEF-MEDINET signs license contract for NeoCart with Histogenics

* Says it entered into a license contract for development and sale of autologous cultured chondrocyte named NeoCart, with Histogenics Corp

BRIEF-Histogenics Corp announces Q3 loss per share $0.23

* Histogenics Corporation announces third quarter 2017 financial and operating results

Select another date: